ISSN X (Print) RC, Mandhana, Kanpur , Uttar Pradesh, India. *Corresponding author Dr. Nutan Saxena

Similar documents
Photodisruptive Nd:YAG laser in the management of premacular subhyaloid hemorrhage

Case Report Nd: YAG laser puncture for spontaneous premacular hemorrhage

Macular hole secondary to Valsalva retinopathy after doing push-up exercise

Accidental foveal burn following pan retinal photocoagulation and its long-term outcome

International Journal of Health Sciences and Research ISSN:

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

Recurrent intraocular hemorrhage secondary to cataract wound neovascularization (Swan Syndrome)

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

Original Article Early treatment with Nd:YAG laser membranotomy and spectral-domain OCT evaluation for Valsalva retinopathy

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Clinically Significant Macular Edema (CSME)

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Retinal Imaging Conference. Brooke LW Nesmith, M.D. University of Louisville Department of Ophthalmology and Visual Sciences 8/7/2014

Fundus Fluorescein Angiography in Diabetic Retinopathy: Correlation of Angiographic Findings to the Clinical Maculopathy Abstract: Purpose:

A Patient s Guide to Diabetic Retinopathy

NO FINANCIAL INTERESTS ARE DISCLOSED BY THE AUTHORS

Surgical outcome of pars plana vitrectomy: a retrospective study in a peripheral tertiary eye care centre of Nepal

VITREOUS FLOATERS AND PHOTOPSIA AS PREDICTORS OF VITREORETINAL PATHOLOGY

EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD

Moncef Khairallah, MD


OCT Assessment of the Vitreoretinal Relationship in CSME

PART 1: GENERAL RETINAL ANATOMY

EFFECTIVENESS OF RADIAL OPTIC NEUROTOMY FOR ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION ABSTRACT

Tuberous sclerosis presenting as atypical aggressive retinal astrocytoma with proliferative retinopathy and vitreous haemorrhage

Vitrectomy for Diabetic Cystoid Macular Edema

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)

Diabetic Retinopathy Screening in Hong Kong. Dr. Rita Gangwani M.S, FRCS (Ophth), FCOphth(HK), FHKAM Eye Institute, The University of Hong Kong

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital

Diabetic Retinopathy

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Diabetic Retinopathy

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic

Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD

FRANZCO, MD, MBBS. Royal Darwin Hospital

A retrospective nonrandomized study was conducted at 3

The use of a high-intensity laser to create an anastomotic

Use of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus

Vitrectomy for Diabetic Retinopathy The current role of pars plana vitrectomy for diabetic macular edema and proliferative diabetic retinopathy.

FA Conference. Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

optic disc neovascularisation

Vascular Disease Ocular Manifestations of Systemic Hypertension

Perspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal

Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?

Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient

Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy

New vessel formation in retinal branch vein occlusion

Vitrectomy Combined with Phacoemulsification and Intraocular Lens Implantation for Diabetic Macular Edema

Visual and Anatomical Outcomes of Vitreous Surgery for Large Macular Holes

Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

OCULAR HEMORRHAGES. ROSCOE J. KENNEDY, M.D. Department of Ophthalmology

Epiretinal Membrane Formation in Terson Syndrome

Extensive argon laser photocoagulation in the

Ophthalmology Macular Pathways

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

Oishi A, Miyamoto K, Yoshimura N. Etiology of carotid cavernous fistula in Japanese. Jpn J Ophthalmol. 2009;53:40-43.

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation

Laser and Anti Vascular Endothelial Growth Factor Agent Treatments for Retinal Arterial Macroaneurysm

Posterior Segment Update

World Sight Day Case Studies. Mark Frost Screening Manager South East London DESP

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

Sudden Vision Loss. Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists

RETINAL CONDITIONS RETINAL CONDITIONS

Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and

Andrew J. Barkmeier, MD; Benjamin P. Nicholson, MA; Levent Akduman, MD

Intravitreal triamcinolone staining observation of residual undetached cortical vitreous after posterior vitreous detachment

Diabetic Retinopatathy

Five Things You re Missing with Your Fundus Camera

Retinal arterial macroaneurysm causing multilevel retinal hemorrhage

Introduction How the eye works

Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion

An Update on Branch Retinal Vein Occlusion Treatment Studies. Amiee Ho, O.D. Pacific University College of Optometry

Variability of IOP following laser photocoagulation used in the treatment of diabetic retinopathy

Outline. Outline. Vitreous Development & Anatomy OPT - 243

Spontaneous Regression of Neovascularization at the Disc in Diabetic Retinopathy

Vanderbilt Eye Institute Clinical Trials

VISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT

Ocular Complications after Intravitreal Bevacizumab Injection in Eyes with Choroidal and Retinal Neovascularization

Intravitreal bevacizumab for pediatric exudative retinal diseases

Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy?


An A to Z guide on Epiretinal Membranes (ERMs) Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Department

THE DEVELOPMENT OF FLUORESCEIN ANGIOGRAphy

Navilas Clinical Results: Diabetic Macular Edema Introducing a Better Treatment Paradigm for Patients and Physicians

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA

A Case of Childhood Vitrectomy Performed for Dense Vitreous Hemorrhage Secondary to Leukemia Therapy and Tumor Lysis Syndrome

Large capillary aneurysms secondary to retinal venous obstruction

Assisting in Ophthalmology. Copyright 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved.

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Diabetologia 9 by Springer-Verlag 1978

Clinical Study Acute-Onset Vitreous Hemorrhage of Unknown Origin before Vitrectomy: Causes and Prognosis

A Case of Carotid-Cavernous Fistula

Study of 189 Cases of Diabetic Retinopathy at CMC Larkana

Transcription:

Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2015; 3(9B):3302-3306 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com ISSN 2320-6691 (Online) ISSN 2347-954X (Print) Research Article Comparative study of Treatment of Premacular subhyaloid Haemmorrhage between conservative Vs Nd-YAG Laser Hyaloidectomy in tertiary care Centre Nutan Saxena 1, Anita Thakur 2, A.M.Jain 3, Ruchika Agarwal 4 1 Assistant Professor, 2 Associate Professor, 3 Professor, 4 Assistant Professor, Department of Ophthalmology, RMCH & RC, Mandhana, Kanpur-209217, Uttar Pradesh, India *Corresponding author Dr. Nutan Saxena Abstract: Premacular subhyaloid hemorrhage is one of the etiologies of sudden visual loss. It might be due to vascular or blood abnormalities or Valsalva retinopathy. Spontaneous absorption of blood may take months and result in macular complications and permanent impairment of vision as stated in my study. Posterior hyaloidectomy by Nd-YAG laser is an outpatient procedure which may avoid the need for complex surgical interventions. This study evaluates the success of this approach in patients with premacular subhyaloid hemorrhage of different etiologies as compared to patients treated conservatively. The study was conducted in Rama Medical College Hospital and Research Centre (RMCH & RC) from August 2012 to December 2013. It includes 14 eyes of 14 patients. We divided patients in two groups of seven patients in each group. One group of seven patients for conservative treatment while other group had Nd -YAG laser hyaloidectomy. The mean pretreatment hemorrhage measured 2.28 disc diameters (range 1.0-3.0) and mean duration of haemorrhage is 1.85 days both in conservatively treated patients as well as in patients who had undergone Nd- YAG laser hyaloidectomy. Visual acuity in all cases before treatment was hand movement to 3/60.Conservatively treated patients could not regain visual acuity 6/6 while patients who had undergone Nd-Yag hyaloidectomy regained visual acuity 6/6 after treatment. No retinal damage or rebleeding occurred due to the laser treatment. Nd- YAG laser hyaloidectomy is very much useful for treating sub macular hyaloid haemorrhage as compared to conservative treatment. Keywords: Nd-YAG laser, Premacular subhyaloid hemorrhage, Nd-YAG laser posterior hyaloidectomy, Proliferative diabetic retinopathy INTRODUCTION Subhyaloid hemorrhage is defined as a localized detachment of vitreous from the retina caused by the accumulation of blood, which can lead to sudden and severe loss of vision, when it takes place in the macular area. Subhyaloid hemorrhage may occur in retinal vascular disorders such as proliferative diabetic retinopathy, branch retinal vein occlusion, macro aneurysm, and age related macular degeneration; in hematological disorders such as leukemia [1] and chemotherapy, induced pancytopenia [6]; following laser keratomileusis (LASIK) because of rapid release of the microkeratome vacuum pressure; or after retinal vascular rupture associated with physical exertion (Valsalva retinopathy) [1-6]. Valsalva retinopathy often occurs in healthy young adults as a result of heavy lifting, straining on toilet, vomiting, coughing. Spontaneous resorption of the blood entrapped in subhyaloid space may take months and may result in permanent visual impairment due to pigmentary macular changes or formation of epiretinal membranes [7] and toxic damage to the retina due to prolonged contact with hemoglobin and Iron4. Different techniques have been used to treat premacular hemorrhage. These include conservative treatment, Nd- Yag laser hyaloidectomy, pars plana deep vitrectomy [8, 9] and pneumatic displacement of hemorrhage by intravitreal injection of gas and tissue plasminogen activator[10]. Puncturing the posterior hyaloid face with Nd-YAG or green argon laser is a safe and easy alternative for releasing the entrapped subhyaloid blood into the vitreous [11-13]. Consequently, the obscured macular area is cleared and resorption of blood cells is facilitated. MATERIAL AND METHODS: The study was conducted in Rama Medical College Hospital and Research Centre (RMCH&RC) from August 2012 to December 2014. It includes 14 eye patients. Patient was registered in Retina Clinic. We only include cases of premacular subhyaloid hemorrhage. We divided patients in two groups of 3302

seven patients in each group. One group of seven patients had conservative treatment while other group of seven patients had Nd-YAG laser hyaloidectomy. Proper history and ocular examination like best corrected visual acuity, tonometry, slit lamp examination and fundoscopy was done. Thorough systemic examination was done to exclude any systemic illness. Complete blood counts including haemoglobin, total and differential leucocyte count, platelets count, liver function test, renal function test including serum creatinine and blood sugar(fasting and postprandial)was done. Fundus photograph was taken and repeated visual acuity was taken.seven patients are conservatively treated and rest 7 patients were included for Nd- YAG laser hyaloidectomy. We give conservative treatment in form of steroid, nonsteroidal anti-inflammatory drug, vitamin C and topical nepafenic etc. This treatment was continued at least for three to six months and they were reviewed time to time as per schedule. Patients included for Yag Laser Hyaloidectomy proper consent was taken and one drop of tropic amide 1% was instilled in affected eye. After dilatation Nd- YAG laser hyaloidectomy was done and fundus photograph was taken (Figure 1&2). Laser was applied to the lowermost dependent part of the blood-containing subhyaloid pocket in order to enhance the blood release process and better protection of the underlying retina. Rest 7 patients were treated conservatively and medical treatment was given. The main outcome measures including success rate in performing hyaloidectomy, releasing the entrapped blood into the vitreous cavity and its resorption, postoperative improvement in visual acuity, and postoperative complications were recorded and analyzed subsequently best visual acuity was taken at 1week, 4 weeks and after 12 weeks. Table-1 Age Distribution Age distribution No. of patients N % 20 30 years 3 21.43 31 40 years 7 50.00 41-50 years 4 28.57 Total 14 100 Table 2Sex Distribution Sex Distribution No. of patients N % Male 6 42.86 Female 8 57.14 Total 14 100 Table-3 Patients on conservative treatment S.No Age/sex OD/OS Diagnosis Size of Duration Pretreatment 1wk 4wk 12wk h ge of h ge V.A 1. 50/F OD PDR 2DD 2 DAYS H.M H.M CF 1feet 6/60 2. 28/M OD Valsalva 2DD 1 DAYS 6/60 6/36 6/18 6/9-2 3. 36/M OS Traumatic 2DD 2 DAYS 6/60 6/18 6/9 6/6-1 4. 37/M OD Valsalva 2DD 2 DAYS 6/60 6/24 6/9-3 6/6-2 5. 39/F OS PDR 3DD 3 DAYS H.M CF 2feet CF 4feet 3/60 6. 23/M OD Idiopathic 2DD 1 DAYS 6/60 6/36 6/18 6/9 7. 45/F OS CRVO 3 DD 2 DAYS 3/60 4/60 6/60 6/18 Table-4 Patients on Nd-Yag laser hyaloidectomy S.No Age/sex OD/OS Diagnosis Size of a h ge Duration of h ge Prelaser V.A Postlaser V.A(1wk) 4wk 12wk Energy (mj) No. of Spots 1. 37/F OS Valsalva 1DD 1 DAY 6/60 6/18 6/9 6/6 5.6 2 2. 46/M OD PDR 3DD 3 DAYS HM 6/60 6/36 6/24 5.8 6 3. 38/F OD PDR 2DD 3DAYS 3/60 6/36 6/18 6/9 5.2 4 4. 25/F OD Traumatic 2DD 2DAYS 6/60 6/18 6/9 6/6 4.8 4 5. 32/M OS idiopathic 2DD 1 DAY 6/36 6/9 6/6 6/6 5.0 3 6. 39/F OS idiopathic 3DD 2DAYS 6/60 6/12 6/6 6/6 5.0 4 7. 43/F OD CRVO 3DD 1 DAY H.M 6/60 6/18 6/6-3 5.2 5 3303

Fig-1: Subhyaloid hemorrhage Fig-2: Post Laser Hyaloidectomy RESULTS The success of laser treatment was defined by clearing of premacular haemorrhage as soon as possible. Fourteen eyes of 14 patients with different diagnosis were enrolled in this interventional series. These included 8 females and 6 males, with an average age of 37 years (range: 23 to 50 years). Four (28.57 %) had proliferative diabetic retinopathy and three patients (21.42 %) had macular subhyaloid haemorrhage due to Valsalva maneuver & idiopathic.2(14.29%) patients had macular subhyaloid haemorrhage due to trauma and CRVO. The seven eyes of seven patients in whom 2(28.57%) cases of proliferative diabetic retinopathy, Valsalva maneuver and of trauma while 1(14.29%) case of CRVO were treated conservatively. The mean pretreatment haemorrhage as judged by fundus photography was 2.28 disc diameters in conservatively treated patients as well as in patients who had undergone Nd- YAG laser hyaloidectomy and mean duration of haemorrhage also is 1.85 days in both categories. Among conservatively treated patients of proliferative diabetic retinopathy, they regain visual acuity from Hand movement (pretreatment) to 3/60(after 12 weeks of treatment) while CRVO patient regained good visual acuity from 6/60(pretreatment) to 6/18 (after 12 weeks of treatment). Because both eyes with proliferative diabetic retinopathy that were treated conservatively develop diffuse macular oedema for which green laser photocoagulation and intravitreal Avastin were given while in eyes with CRVO also develop macular oedema for which also intravitreal Avastin was given. The eyes with Valsalva maneuver, 3304

traumatic or idiopathic develop mild macular oedema which later on subside After three months patients suffering from traumatic or Valsalva maneuver got very good visual acuity up to6/6-1 (Table-3). Drainage of premacular subhyaloid haemorrhage with Nd: YAG posterior hyaloidectomy among proliferative diabetic retinopathy causes good visual acuity recovery (from hand movement to 6/24). In this also one case needs green laser photocoagulation followed by intravitreal Avastin injection. CRVO patient also regained good visual acuity hand movement (prelaser) to 6/6-3.That patients could not gain 6/6 vision due to mild macular oedema which subsides later on. Other patients e.g. traumatic, idiopathic or Valsalva maneuver got full visual acuity 6/6. The mean power required to perform posterior hyaloidectomy was 5.22mJ and the mean spot size is 4. Conservatively, One, four and twelve weeks after treatment, visual acuities ranged respectively from Hand movement to 6/18, Counting figure to 6/9 and3/60 to 6/6-1. Overall, visual improvement was best in eyes with Valsalva retinopathy and trauma irrespective of treatment whether patients were treated conservatively or Nd -YAG laser hyaloidectomy were done. Eyes with proliferative diabetic retinopathy or central retinal vein occlusion also regained vision, but recovery was usually limited by the macular or retinal disease and eyes with valsalva, trauma or idiopathic reason gained visual acuity 6/9-6/18 after one week & 6/6 after 12 weeks. The hemorrhage usually clears spontaneously, but it may take several months if [7, 14, 15] treated conservatively. There is controversy on the effects of preretinal blood on the retina itself, as epiretinal membrane may be induced and a toxic effect of dissolving hemoglobin has been suggested after long contact between blood and retina [7, 11, 14]. In other words, spontaneous resolution of a subhyaloid hemorrhage may leave the eye with permanent macular changes [7, 14]. Rupturing the posterior hyaloid requires accurate focusing over the anterior surface of the hemorrhage; otherwise optical breakdown will not occur, since the irradiance needed to start plasma formation cannot be achieved [14]. Serious complications such as hemorrhage, retinal holes and macular injuries can result from Nd-YAG laser application of the posterior segment [11,16] and these may be important for small premacular subhyaloid hemorrhage, which is considered self-limiting 1, 11. Therefore, Ulbig et al.; advocate laser drainage only if the hemorrhage is bigger than three disc diameters [11]. The mean size of the premacular subhyaloid hemorrhages here was 4.0 disc diameters and no retinal injury was observed in any of our cases. One eye with proliferative diabetic retinopathy had neovascularization and green laser photocoagulation was done. The other cases had no evident new vessels or macular edema after posterior hyaloidectomy and needed no further treatment. Other patients who had under gone Nd-Yag laser hyaloidectomy develop no macular complications unlike patients with conservative treatment. DISCUSSION Subhyaloid hemorrhage is defined as a localized detachment of vitreous from the retina lead to sudden and severe loss of vision when it takes place in the macular area1-3. Subhyaloid hemorrhage or subinternal limiting membrane hemorrhage in the macula may occur membrane hemorrhage in the macula may occur (Valsalva retinopathy) or in retinal vascular diseases, such as proliferative diabetic retinopathy, and retinal macro aneurysm [2, 11, 13]. Ulbig et al studied 21 patients with premacular subhyaloid hemorrhage of different etiologies. Hyaloidotomy was successful in 16 (76.2%) of their patients, with visual improvement in all. Final BCVA was better in patients with Valsalva retinopathy compared with other etiologies and approached normal levels after treatment [12]. Gabel et al.; evaluated 3 patients with premacular subhyaloid hemorrhage. Nd-YAG laser hyaloidotomy was successful in all cases, and one patient with Valsalva retinopathy after military operation gained full vision postoperatively [13]. Considering the results of this investigation and that of previous studies, we may conclude that Nd YAG laser hyaloidotomy is a simple, inexpensive outpatient procedure which is relatively safe compared with other more complex operations such as deep vitrectomy and its potentially serious complications. It results in rapid visual recovery and especially very good outcomes in patients with Valsalva retinopathy. This technique can prevent long-term entrapment of blood and its adverse effects on macula including potential permanent loss of vision. Further studies including controlled clinical trials to compare this treatment with other modalities (e.g. deep vitrectomy) or spontaneous absorption of subhyaloid blood are warranted before drawing more definite conclusions. CONCLUSION From the above study, it is clear that Nd-YAG laser hyaloidectomy much beneficial in treatment of macular hyaloid haemorrhage as compared to conservative treatment. REFERENCES 1. Gass JDM; Stereoscopic Atlas of Macular Diseases. 3rd ed. St Louis: CV Mosby; 1987. 2. Khairallah M, Ladjimi A, Messaoud R, Ben Yahia S, Hmidi K, Jenzeri S; Retinal venous macro 3305

aneurysm associated with premacular hemorrhage. Ophthalmic Surg Lasers. 1999; 30: 226 228. 3. Duane TD; Valsalva hemorrhagic retinopathy. Trans Am Ophthalmol Soc. 1972; 70: 298 313. 4. Rennie CA, Newman DK, Snead MP, Flanagan DW; Nd-YAG laser treatment for premacular subhyaloid hemorrhage. Eye. 2001; 15: 519 524. 5. Cheung CM, Benson MT; Post chemotherapy premacular subhyaloid hemorrhage. Eye. 2003; 17: 97 99. 6. Mansour AM, Ojeimi GK; Premacular subhyaloid hemorrhage following laser in situ keratomileusis. J Refract Surg. 2000; 16: 371 372. 7. O'Hanley GP, Canny CL; Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology. 1985; 92: 507 511. 8. Zhao P, Hayashi H, Oshima K, Nakagawa N, Ohsato M; Vitrectomy for macular hemorrhage associated with retinal arterial macro aneurysm. Ophthalmology. 2000; 107: 613 617. 9. Ramsay RC, Knobloch WH, Cantrill HL; Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology. 1986; 93: 283 289. 10. Conway MD, Peyman GA, Recasens M; Intravitreal TPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome. Ophthalmic Surg Lasers. 1999; 30: 435 441. 11. Ulbig MW, Mangouritsas G, Rothbacher HH, Hamilton AM, McHugh JD; Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd: YAG laser. Arch Ophthalmol. 1998; 116: 1465 1469. 12. Celebi S, Kukner AS; Photo disruptive Nd-YAG laser in the management of premacular subhyaloid hemorrhage. Eur J Ophthalmol. 2001; 11: 281 286. 13. Gabel VP, Birngruber R, Gunther-Koszka H, Puliafito CA; Nd-YAG laser photodisruption of hemorrhagic detachment of the internal limiting membrane. Am J Ophthalmol. 1989; 107: 33 37. 14. Kaynak S, Eryildirim A, Kaynak T, Durak I, Saatçi O, Eryildirim S et al.; Nd: YAGlaser posterior hyaloidotomy in subhyaloid hemorrhage. Ophthalmic Surg 1994; 25(7): 474-6. 15. Raymond LA; Neodymium: YAG laser treatment for hemorrhages under the internal limiting membrane and posterior hyaloid face in the macula. Ophthalmology 1995; 102: 406-11. 16. Thach AB, Lopez PF, Snady-McCoy LC, Golub BM, Frambach D; Accidental Nd: YAG laser injuries to the macula. Am J Ophthalmol 1995; 119: 763-73. 17. Schipper T; Valsalva s maneuver: not always benign. Klin Monatsbl Augenheilkd 1991; 198: 457-9. 3306